Senseonics Holdings, Inc. (SENS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
20451 Seneca Meadows Parkway
Germantown, MD 20876-7005
United States of America (the)
Phone
301 515 7260
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
117
First IPO Date
December 22, 2015
| Name | Title | Pay | Year Born |
| Timothy T. Goodnow | President, Chief Executive Officer & Director | 1.3M | 1962 |
| Frederick T. Sullivan | Chief Financial Officer, Secretary & Treasurer | 692,599 | 1982 |
| Kenneth L. Horton | General Counsel & Corporate Development Advisor | 750,712 | 1967 |
| Mukul Jain | Chief Operating Officer | 945,166 | 1973 |
| Brian Hansen | Chief Commercial Officer & Director | 0 | 1968 |
| Francine Ratner Kaufman | Chief Medical Officer & Director | 0 | 1951 |
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.